Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-2 of 2
Keywords: diabetic nephropathy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
SRPK1 inhibition in vivo : modulation of VEGF splicing and potential treatment for multiple diseases
Available to PurchaseSebastian Oltean, Melissa Gammons, Richard Hulse, Maryam Hamdollah-Zadeh, Athina Mavrou, Lucy Donaldson, Andrew H. Salmon, Steve J. Harper, Michael R. Ladomery, David O. Bates
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2012) 40 (4): 831–835.
Published: 20 July 2012
... in regulation of many cellular processes. It is therefore crucial to carry out overexpression and inhibition studies in vivo to fully characterize the essential as well as redundant SRPK1 functions in physiology and pathology. age-related macular degeneration diabetic nephropathy hepatitis C virus...
Articles
Regulation and consequences of differential gene expression in diabetic kidney disease
Available to Purchase
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2008) 36 (5): 941–945.
Published: 19 September 2008
...Madeline Murphy; John Crean; Derek P. Brazil; Denise Sadlier; Finian Martin; Catherine Godson DN (diabetic nephropathy) is the leading cause of end-stage renal disease worldwide and develops in 25–40% of patients with Type 1 or Type 2 diabetes mellitus. Elevated blood glucose over long periods...
